256
Participants
Start Date
January 23, 2018
Primary Completion Date
July 21, 2019
Study Completion Date
November 20, 2019
CaPre
4 x 1 g capsules administered orally once a day for 26 weeks
Placebo
4 x 1 g capsules administered orally once a day for 26 weeks
Research site, Beaver
Research site, Danville
Research site, Greensboro
Research site, Mooresville
Research site, Spartanburg
Research site, Snellville
Research site, Atlanta
Research site, Gainesville
Research site, Sugar Hill
Research site, Savannah
Research site, Jacksonville
Research site, Orlando
Research site, Hialeah
Research site, Pembroke Pines
Research site, Homestead
Research site, Miami
Research site, Miami
Research site, Miami
Research site, Miami
Research site, Miami
Research site, North Miami Beach
Research site, Miami
Research site, Miami Springs
Research site, Miami
Research site, Kendall
Research site, Tamarac
Research site, West Palm Beach
Research site, West Palm Beach
Research site, Wellington
Research site, Lake Worth
Research site, Boca Raton
Research site, Tampa
Research site, Clearwater
Research site, Fort Myers
Research site, Birmingham
Research site, Chattanooga
Research site, Memphis
Research site, Olive Branch
Research site, Jackson
Research site, Louisville
Research site, Marion
Research site, Maumee
Research site, Canton
Research site, Anderson
Research site, Cadillac
Research site, Kenosha
Research site, Gurnee
Research site, St Louis
Research site, Omaha
Research site, Eunice
Research site, Conway
Research site, Norman
Research site, Arlington
Research site, Lampasas
Research site, Houston
Research site, Houston
Research site, San Antonio
Research site, Meridian
Research site, Meridian
Research site, West Jordan
Research site, Salt Lake City
Research site, Tucson
Research site, Lomita
Research site, El Cajon
Research site, Newport Beach
Research site, Tustin
Research site, Garden Grove
Research site, Fresno
Research site, Bellevue
Lead Sponsor
Grace Therapeutics Inc.
INDUSTRY